Navigation Links
Kensey Nash to Participate in the Friedman Billings Ramsey 12th Annual Spring Investor Conference
Date:5/23/2008

EXTON, Pa., May 23 /PRNewswire-FirstCall/ -- Kensey Nash Corporation (Nasdaq: KNSY) is scheduled to present at the FBR 12th Annual Spring Investor Conference at the Grand Hyatt New York Hotel in New York City on Wednesday, May 28, 2008.

Douglas G. Evans, Kensey Nash's COO, will deliver the Company's presentation, beginning at approximately 12:50 p.m. (EDT). To hear the live webcast of the Kensey Nash presentation at the FBR conference, go to http://www.wsw.com/webcast/fbr21/knsy/ and access the conference link. The presentation materials will be available on the company's website (http://www.kenseynash.com) beginning at 12:50 p.m. (EDT) on Wednesday, May 28, 2008.

About Kensey Nash Corporation. Kensey Nash Corporation is a leading medical technology company providing innovative solutions and technologies for a wide range of medical procedures. The Company provides an extensive range of products into multiple medical markets, primarily in the sports medicine, spine, and endovascular markets. Many of the products are based on the Company's significant expertise in the design, development, manufacturing and processing of absorbable biomaterials, which has led to partnerships to commercialize technologies. Kensey Nash has also developed and commercialized a series of innovative endovascular products and recently announced the sale of this product line to Spectranetics, Inc. In conjunction with the sale transaction, the Company will continue to manufacture and develop these products for Spectranetics for a period of time. The Company is known as a pioneer in the field of arterial puncture closure, as the invent
'/>"/>

SOURCE Kensey Nash Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Corrected Press Release: Kensey Nash to Present at the Bank of America 2008 Health Care Conference
2. Kensey Nash to Present at the Bank of America 2008 Health Care Conference
3. Kensey Nash Reports Third Quarter Record Revenue and Sales
4. Kensey Nash to Participate in the Sidoti Twelfth Annual New York Emerging Growth Institutional Investor Forum Conference
5. Kensey Nash Reports Second Quarter EPS of $0.21 and Revenue of $19.6 Million
6. Kensey Nash Corporation Announces Its Second Quarter 2008 Earnings Release Date and Teleconference
7. Kensey Nash to Present at the 19th Annual Piper Jaffray Health Care Conference
8. Kensey Nash Announces Exclusive License of Optical Guidance Patent to Enhance Chronic Total Occlusion Platform
9. Kensey Nash Reports First Quarter Fiscal Year 2008 Results
10. Kensey Nash Reports Acceleration of Stock Awards Triggered by Shareholder Acquisition of Greater Than 20% of Outstanding Shares
11. Kensey Nash Announces $25 Million Stock Repurchase Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... (PRWEB) May 06, 2015 Wolters ... healthcare professionals and students, announced today that in a ... confirmed that use of the clinical decision support resource ... the end of 2014, UpToDate users in more than ... topics per month, on average. In Germany alone, 95% ...
(Date:5/6/2015)... TX (PRWEB) May 06, 2015 ... 1,000 user mark after launching in mid-February. The company ... candidates who have previous experience in the industry. Likewise, ... profession. , According to Kyle Johnson, CTO, unique traffic ... to the first month: "Each new job posting brings ...
(Date:5/6/2015)... 06, 2015 Locally owned, Greek olive oil ... this past week as having one the best Extra Virgin ... from the Peloponnese region of Greece and known as ... the category of Medium Olive Oil, which is defined by ... With over 700 producer applicants from 25 different countries ...
(Date:5/6/2015)... Dr. Vito C. Quatela, one of upstate New York’s ... medical mission trip to Hanoi, Vietnam with the HUGS Foundation ... and other deformities of the face. , During the 10-day ... 26, Dr. Quatela and his team performed microtia surgeries on ... the outside of the ear is underdeveloped. This condition is ...
(Date:5/6/2015)... Los Angeles, California (PRWEB) May 06, 2015 ... has secured its first round of VC funding and ... , The enterprise class embeddable software enables applications ... transform data as it moves between systems and locations. ... the HyperTransfer technology moves files at line speed, independent ...
Breaking Medicine News(10 mins):Health News:Current, Evidence-Based Knowledge for Physicians: UpToDate supports quick and accurate decision support for diagnosis and treatment 2Health News:Current, Evidence-Based Knowledge for Physicians: UpToDate supports quick and accurate decision support for diagnosis and treatment 3Health News:Job Seekers Turn to JobMedic to Find Healthcare Positions - JobMedic.com Reaches 1,000 User Milestone 2Health News:Greek Extra Virgin Olive Oil, Laconiko Wins Gold at the NYIOOC and Is Featured in Olive Oil Times as One of Greece's Best EVOO's for 2015 2Health News:Dr. Vito Quatela Completes Successful 10-Day Medical Mission Trip to Hanoi, Vietnam 2Health News:Dr. Vito Quatela Completes Successful 10-Day Medical Mission Trip to Hanoi, Vietnam 3Health News:TransferSoft Launches Industry’s Most Comprehensive Data Movement Technology Suite to Optimize Disaster Recovery, Big Data, and Cloud Applications 2Health News:TransferSoft Launches Industry’s Most Comprehensive Data Movement Technology Suite to Optimize Disaster Recovery, Big Data, and Cloud Applications 3Health News:TransferSoft Launches Industry’s Most Comprehensive Data Movement Technology Suite to Optimize Disaster Recovery, Big Data, and Cloud Applications 4
... completely implantable artificial heart was approved by the U.S. ... heart has been approved for patients with severe heart ... ,Under the FDA's Humanitarian Use Device provisions, ... However, it restricts the use of more than 4,000 ...
... 300 million poultry next month against bird flu.// ... large-scale criticism over the country's efforts to stamp out ... mass vaccination today. Indonesia has the world's highest human ... in the world and scientists and the World Bank ...
... An engineer has developed a new system that could help ... ,An engineer Fernando Silvio Nu?o Almirantearena has developed a ... heart attack, brain stroke or high blood pressure, by determining ... techniques. Fernando has outlined in his thesis for PhD the ...
... in the Journal of Clinical Investigation and the September issue ... that a new drug helps in reducing the risk of ... flow in diseased arteries. The new drug developed by ... by free radicals, which helps in dilatation of the arteries. ...
... worked at Ground Zero after 9/11 are struggling with serious ... advocates.// "When we were needed on 9/11, no one asked ... said Lucelly Gil, who was present in the disaster zone. ... illegal immigrants to work in danger zone without providing the ...
... asked EU health authorities to re-examine data related to ... Committee for Medicinal Products for Human Use (CHMP) had ... cancer need new treatment options like Tarceva, which has ... and has already been approved for this indication in ...
Cached Medicine News:Health News:First Implantable artificial heart gets FDA’s approva 2Health News:Indonesia To Conduct Mass Vaccination Of Poultry 2Health News:A New System Developed For Studying The Condition Of The Human Arterial System 2Health News:A New Drug That Could Revolutionize Management Of Heart Disease 2
(Date:5/6/2015)... , May 06, 2015 Research and Markets ... addition of the "Asia-Pacific Internal Trauma Fixation ... Analysis and Forecast To 2019" report to ... Fixation Devices market is estimated to grow at ... Factors, such as technological advancement, rising incidences of ...
(Date:5/6/2015)... DIEGO , May 6, 2015  MEI Pharma, Inc. ... clinical development of novel therapies for cancer, announced today that ... Officer, will present at the Bank of America Merrill Lynch ... 8:00 a.m. Pacific time from the Encore at the Wynn ... of the presentation can be accessed at www.meipharma.com . ...
(Date:5/6/2015)... 6, 2015 Adaptive Biotechnologies, a leader ... T-cell and B-cell receptors in the immune system, ... financing round with a $195 million investment to ... led by Matrix Capital Management and included other ... Springs Capital and an additional large healthcare investor, ...
Breaking Medicine Technology:Asia-Pacific Internal Trauma Fixation Devices (Internal Trauma Fixation Plates, Screws, Rod Wires & Pins, Fusion Nails) Market 2015 2MEI Pharma to Present at Bank of America Merrill Lynch Health Care Conference 2Adaptive Biotechnologies Enhances Leading Position in Growing Immunosequencing Market with Completion of $195 Million Investment 2
... MYL ) today announced its financial results for the ... , Adjusted diluted EPS of $0.52 for the three ... prior year period, an increase of 18%; , Adjusted ... 31, 2012 compared to $1.45 billion for the same prior year ...
...  Galenea Corp., a leader in the rapidly emerging ... Stanley Medical Research Institute (SMRI) will provide $6 ... development of Galenea,s innovative pro-cognitive discovery program and ... treatment of schizophrenia and other psychiatric disorders.  The ...
Cached Medicine Technology:Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter 2Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter 3Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter 4Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter 5Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter 6Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter 7Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter 8Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter 9Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter 10Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter 11Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter 12Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter 13Galenea to Receive $6 Million From The Stanley Medical Research Institute to Progress Pro-Cognitive Drug Discovery and Development Program 2Galenea to Receive $6 Million From The Stanley Medical Research Institute to Progress Pro-Cognitive Drug Discovery and Development Program 3
Bio-Rad's ScanGel® cards for ABO reverse grouping, antibody screening and crossmatching include - ScanGel Neutral, ScanGel Coombs, Anti-IgG, -C3d (AHG), ScanGel Coombs + Neutral, ScanGel Anti-Ig...
... The Criterion Dodeca cell, a component of ... run up to 12 Criterion gels in a ... (13.3 x 8.7 cm) than the traditional mini ... strips to give you the optimal combination of ...
... Plus Dodeca cell accommodates up to 12 ... first-dimension runs in the PROTEAN IEF system, ... format. The PROTEAN Plus Dodeca cell's cooling ... electrodes, allow consistent, high-resolution results. The handcasting ...
... The ElectroXpress gel electrophoresis system mirrors a ... high-throughput screening of PCR products to take ... the source (96-well) plate. Loading can be carried ... the first time in the industry two ...
Medicine Products: